Using recombinant human epidermal growth factor with standard of good care for diabetic foot ulcers in inoperable patients

• ISSUE 2008
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds

• ISSUE 2008
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

The effect of recombinant human epidermal growth factor on cisplatin and radiotherapy induced oral mucositis in mice

• ISSUE 2007
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer

• ISSUE 2007
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

Effect of epidermal growth factor against radiotherapy-induced oral mucositis in rats

• ISSUE 2007
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

Expression of tumor necrosis factor-alpha and cyclooxygenase-2mRNA in porcine split-thickness wounds treated with epidermal growth factor by quantitative real-time PCR

• ISSUE 2007
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

Effects of recombinant human epidermal growth factor on the proliferation and radiation survival of human fibroblast cell lines in vitro

• ISSUE 2006
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

Effects of recombinant human epidermal growth factor (rhEGF) on experimental radiation-induced oral mucositis in rats

• ISSUE 2006
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers

• ISSUE 2006
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29

Treatment of acute and chronic wound in immunodeficiency patients using Easyef®

• ISSUE 2006
• CATEGORY Wound
• PRODUCT Easyef®
• UPDATE 2017.08.29